These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Treatments for pulmonary arterial hypertension. Liu C; Liu K; Ji Z; Liu G Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344 [TBL] [Abstract][Full Text] [Related]
36. Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility. Rex S; Missant C; Segers P; Rossaint R; Wouters PF Intensive Care Med; 2008 Jan; 34(1):179-89. PubMed ID: 17710383 [TBL] [Abstract][Full Text] [Related]
37. Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension. Castelain V; Chemla D; Humbert M; Sitbon O; Simonneau G; Lecarpentier Y; Hervé P Am J Respir Crit Care Med; 2002 Feb; 165(3):338-40. PubMed ID: 11818317 [TBL] [Abstract][Full Text] [Related]
38. Infections by gram-negative bacilli in patients with pulmonary arterial hypertension treated with intravenous prostacyclin. Gómez Sánchez MA Arch Bronconeumol; 2013 Mar; 49(3):128-9. PubMed ID: 23127721 [No Abstract] [Full Text] [Related]
39. Anti-coagulation complications in pregnancies with severe pulmonary arterial hypertension. Herrero T; Martin E; Poch DS; Roeder HA J Matern Fetal Neonatal Med; 2018 May; 31(9):1209-1213. PubMed ID: 28353362 [TBL] [Abstract][Full Text] [Related]